Strep Throat Treatment Market Share

  • Report ID: 5964
  • Published Date: Apr 03, 2024
  • Report Format: PDF, PPT

Strep Throat Treatment Market Share

North American Market Statistics

The strep throat treatment market in the North America region will have the biggest growth during the forecast period with a revenue share of around 38%. This growth will be noticed owing to the rising advancement in technology in this region. However, Canada is fast becoming a hub for technology within North America, thus the US isn't the only place where technology innovation comes from. Our recent study of over 1,600 technology professionals confirmed the region's technological prowess, with respondents ranking North America as the world's most technologically advanced region.

European Market Analysis

The strep throat treatment market in the Europe region will also encounter huge growth during the forecast period and will hold the second position owing to the rising attainability of healthcare in this region. The Sustainable Development Goals (SDGs) objective 3.8, which calls for universal health coverage by 2030, is not likely to be achieved by the globe on track. Since 2015, progress in expanding access to health services has stalled, and since 2000, the share of the population that had to pay catastrophic amounts out of pocket for medical care has risen steadily. Most countries and all regions of the world follow this worldwide pattern.

Research Nester
Slide2
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5964
  • Published Date: Apr 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of strep throat treatment is evaluated at USD 2.26 billion.

The strep throat treatment market size was over USD 2.18 billion in 2024 and is poised to exceed USD 3.86 billion by 2037, growing at over 4.5% CAGR during the forecast period i.e., between 2025-2037. The rise in several deaths from rheumatic heart disease mainly in industrial fields will drive the market growth.

North America industry is set to dominate majority revenue share of 38% by 2037, owing to rising advancement in technology in this region.

The major players in the market are Pfizer Inc., Astrazeneca, Novartis AG, Bayer AG, GSK plc., Melinta Therapeutics, Amgen Inc., Teva Pharmaceutical Industries Ltd., Merck & co, Inc., Johnson & Johnson Service, Inc., Takeda Pharmaceutical Company Limited, Sanofi, Mitsubishi Chemical Group Corp., Daiichi Sankyo Co Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample